Interestingly, herein we found that RvD1 inhibited COMP in CAFs in a paracrine manner to modulate EMT and cancer stemness in HCC, providing a promising therapeutic strategy for patients with HCC. The gene discussed is COMP; the disease is hepatocellular carcinoma.